BACKGROUND: Limited evidence exists on the prognostic role of continuing medical therapy in patients with heart failure (HF) ...

Patients who have been treated for heart failure and experience an improvement in their pump function are still at higher ...

Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...

Eosinophil Levels may predict prognosis in critically ill patients with HFrEF suggests a study published in the Scientific Reports.Heart failure (HF) is associated with poor prognosis.

China: A recent study highlights the potential risks associated with sarcopenic obesity (SO) in diabetic patients with heart ...

Cytokinetics is now rapidly moving into commercialization efforts with Aficamten. Read more to see why I rate CYTK stock a ...

Fran McCaffery didn’t get to see the end of the Big Ten Tournament game for his Iowa team. He was ejected from the contest ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases by developing a range of next-generation therapeutics. Medera operates via ...

Medera announced that patient dosing has been completed in its MUSIC-HFrEF Phase 1/2a clinical trial of the gene therapy candidate SRD-001 in ...

More frequent placement of central venous catheter seen for patients with heart failure with reduced ejection fraction ...